DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20200230

Clinical study of neurological presentation of diabetes mellitus in a tertiary care hospital

Sadhna Sharma, Shaik Afsar Pasha, Mohammad Khawja Mohidden, E. Srikanth

Abstract


Background: A wide range of commotions affecting the central and peripheral nervous systems, either directly or indirectly, may be observed in patients with diabetes mellitus. The spectrum of neurological complications among diabetes are quite varied.

Methods: Authors conducted a Cross-sectional prospective observational study to study different neurological manifestations of diabetes mellitus. at NRI General Hospital, Chinakakani, Guntur District, Andhra Pradesh. The selected patients were studied in detail with history and physical examination. The investigations included Fasting Blood Sugar (FBS), Postprandial Blood Sugar (PPBS), Glycosylated Hemoglobin (HbA1C).

Results: A total of 100 subjects were included in the final analysis. Majority of participants were aged between 46 to 65 years, and 55% of them were males. Only 13% of the participants had HBA1c value below 7.5 gm%. Out of 100 participants, 82% participants had diabetic peripheral neuropathy. A total of 6 subjects had cranial neuropathy, with 5% participants having 3rd nerve and one participant had 6th nerve. Involuntary movements (Chorea) was present in 4% of patients. Among the people with Seizures, 6% participants had Hyperglycemic, and 2% participants had Hypoglycemic seizures. Out of 100 participants, 7 participants had dysautonomia.

Conclusions: Peripheral neuropathy was the most common neurological manifestation among the diabetic population. The other key neurological abnormalities include cranial nerve palsy, dysautonomia, seizures and Chorea. Clinicians need to be aware the entire spectrum of neurological abnormalities among patients with type 2 Diabetes.


Keywords


Diabetes mellitus, Diabetic neuropathy, Dysautonomia, Neurological abnormalities

Full Text:

PDF

References


American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabe Care. 2013 Jan 1;36(1):S67-74.

Nowotny K, Jung T, Höhn A, Weber D, Grune T. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomol. 2015 Mar 16;5(1):194-222.

Cho N, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabe Res Clin Pract. 2018 Apr 1;138:271-81.

Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, et al. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional study. lancet Diabe Endocrinol. 2017 Aug 1;5(8):585-96.

Papatheodorou K, Papanas N, Banach M, Papazoglou D, Edmonds M. Complications of diabetes 2016. J Diabe Res. 2016; 6989453.

Biessels GJ, Kappelle AC, Bravenboer B, Erkelens DW, Gispen WH. Cerebral function in diabetes mellitus. Diabetologia. 1994 Jul 1;37(7):643-50.

Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabe. 2008 Apr 1;26(2):77-82.

Mahmood T, ul Bari A, Agha H. Cutaneous manifestations of diabetes mellitus. J Pakistan Assoc Dermatol. 2016 Dec 28;15(3):227-32.

Cheema S, Maisonneuve P, Zirie M, Jayyousi A, Alrouh H, Abraham A, et al. Risk factors for microvascular complications of diabetes in a high-risk middle east population. J Diabe Res. 2018; 8964027.

Sadikot SM, Nigam A, Das S, Bajaj S, Zargar AH, Prasannakumar KM, et al. The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: prevalence of diabetes in India study (PODIS). Diabe Res Clin Pract. 2004 Dec 1;66(3):301-7.

Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabe/metabol Res Rev. 2012 Feb;28:8-14.

Tesfaye S. Recent advances in the management of diabetic distal symmetrical polyneuropathy. J Diabe Invest. 2011 Feb;2(1):33-42.

Watkins PJ, Thomas PK. Diabetes mellitus and the nervous system. J Neurol, Neurosurg Psychia. 1998 Nov 1;65(5):620-32.

Selvarajah D, Tesfaye S. Central nervous system involvement in diabetes mellitus. Curr Diab Rep. 2006;6(6):431-8.

Corp IB. IBM SPSS statistics for windows, version 22.0. Armonk, NY: IBM Corp. 2013.

Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'brien PC, et al. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol. 1997 Feb 15;145(4):301-8.

Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, Al-Harthi SS, Arafah MR, Khalil MZ, et al. Diabetes mellitus in Saudi Arabia. Saudi Med J. 2004;25(11):1603-10.

Jadoon NA, Shah N, Karim R, Zafar A, Ijaz A. Frequency of nonalcoholic fatty liver diasease in patients with diabetes mellitus. Soci Endocrinol BES. 2017 2017 Oct 20;50: 223.

Alharithy MK, Alobaylan MM, Alsugair ZO, Alswat KA. Impact of Family History of Diabetes on Diabetes Control and Complications. Endocr Pract. 2018;24(9):773-9.

Arauz-Pacheco C, Parrott MA, Raskin P. Treatment of hypertension in adults with diabetes. Diabe Care. 2003;26:S80.

Zoungas S, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014 Dec 1;57(12):2465-74.

Kenzaka T, Fujikawa M, Matsumoto M. Diabetic chorea as a neurological complication. Clin Case reports. 2018 Jul;6(7):1398.

Baviera M, Roncaglioni MC, Tettamanti M, Vannini T, Fortino I, Bortolotti A, et al. Diabetes mellitus: a risk factor for seizures in the elderly-a population-based study. Acta Diabetol. 2017;54(9):863-70.

Magesh A, Johns I, Kannan VP. A study of prevalence of autonomic dysfunction in type–2 diabetes mellitus in a tertiary care center. JEBMH. 2018;5(15):1316-20.

Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabe Care. 2003 Jun 1;26(6):1790-5.

Jaiswal M, Divers J, Dabelea D, Isom S, Bell RA, Martin CL, Pettitt DJ, et al. Prevalence of and risk factors for diabetic peripheral neuropathy in youth with type 1 and type 2 diabetes: SEARCH for Diabetes in Youth Study. Diabe Care. 2017 Sep 1;40(9):1226-32.

Iqbal Z, Azmi S, Yadav R, Ferdousi M, Kumar M, Cuthbertson DJ, et al. Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy. Clin Ther. 2018;40(6):828-49.

Li L, Chen J, Wang J, Cai D. Prevalence and risk factors of diabetic peripheral neuropathy in type 2 diabetes mellitus patients with overweight/obese in Guangdong province, China. Prim Care Diabe. 2015 Jun 1;9(3):191-5.

Alamgir AN. Pharmacognostical Botany: Classification of medicinal and aromatic plants (MAPs), botanical taxonomy, morphology, and anatomy of drug plants. Therapeutic Use Med Plants Their Extracts. 2017;1:177-293.

Gadkari SS, Maskati QB, Nayak BK. Prevalence of diabetic retinopathy in India: The all India ophthalmological society diabetic retinopathy eye screening study 2014. Ind J Ophthalmol. 2016 Jan;64(1):38.

Sunita M, Singh AK, Rogye A, Sonawane M, Gaonkar R, Srinivasan R, et al. Prevalence of diabetic retinopathy in urban slums: the Aditya Jyot Diabetic Retinopathy in Urban Mumbai Slums Study-report 2. Ophthal Epidemiol. 2017 Sep 3;24(5):303-10.